Langland is delighted to announce the opening of its New York office. Kate Spencer, Langland’s Managing Partner will lead the U.S. operations, reporting to Philip Chin, Langland’s Chief Executive. The opening of the US office marks a milestone in Langland’s plan to take the agency brand to key global markets.
Langland Chief Executive, Philip Chin said: “Our strategy is to scale and replicate the Langland brand internationally as part of Publicis Health to better serve the needs of our clients. Our new office in New York is a significant step forward in executing this strategy. We look forward to establishing new long-lasting client relationships in the US and to building more value for clients who have already entrusted us with their business.”
Langland in the US will provide a full range of integrated global communications services, connecting the combined resources of Publicis Health to deliver creative solutions in clinical trial patient recruitment, corporate communications, prescription medicine and consumer health advertising.
Commenting on the international expansion, Kate Spencer said: “Specifically in the field of clinical trial patient recruitment, Langland has amassed extensive experience and expertise having supported global pharma companies with over 350 studies across 75 countries. The US continues to be a key region in the world from where pharma companies both co-ordinate and conduct global clinical trials. Having an on the ground presence directly in the US will provide us with a greater opportunity to work more closely with our US-based clients.”
Langland’s new office will be based at Publicis Health’s Corporate Headquarters in One Penn Plaza, New York, NY 10119. Telephone: 001 212 771 5500